We performed Gln deprivation and α-KG rescue assays and found that KRAS-mutant CRC cells were sensitive to Gln deprivation, whereas KRAS-WT CRC cells were relatively tolerant of Gln deprivation (Figure 4C). This evidence concerns the gene KRAS and colorectal carcinoma.